Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 22, Issue 1, 2007, Pages 12-20

  Stewart, Gloria Lopez ^a   Tambascia, Marcos ^b   Guzmán, Juan Rosas ^c   Etchegoyen, Federico ^d   Carrion, Jorge Ortega ^e   Artemenko, Sofia ^f  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF GUANAJUATO   (Mexico)

^d UNIVERSIDAD AUSTRAL   (Argentina)

^e Clinica de la FAE Quito   (Ecuador)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Diabetes complications; Diabetes mellitus; Health services accessibility; Latin America; Patient compliance; Type 2

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

BLOOD; DIABETES; DISEASE CONTROL; EDUCATION; HEALTH CARE; PUBLIC HEALTH; QUESTIONNAIRE SURVEY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETIC DIET; FEMALE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HUMAN; KINESIOTHERAPY; LIFESTYLE; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIVATE PRACTICE; SOUTH AND CENTRAL AMERICA; STATISTICS;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; EXERCISE THERAPY; FAMILY PRACTICE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LATIN AMERICA; LIFE STYLE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRIVATE PRACTICE;

LATIN AMERICA;

EID: 35548935582     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5): 1047-53.
2. Hennis A, Wu SY, Nemesure B, Li X, Leske MC, Barbados Eye Study Group. Diabetes in a Caribbean population: epidemiological profile and implications. Int J Epidemiol. 2002; 31(1):234-9.
3. Carulli L, Rond in ella S, Lombardini S, Canedi I, Loria P, Carulli N. Review article: diabetes, genetics and ethnicity. Aliment Pharmacol Ther. 2005;22 (Suppl 2):16-9.
4. Aschner P. Diabetes trends in Latin America. Diabetes Metab Res Rev. 2002;18(Suppl 3): S27-31.
5. Wilks R, Rotimi C, Bennett F, McFarlaneAnderson N, Kaufman JS, Anderson SG et al. Diabetes in the Caribbean: results of a population survey from Spanish Town, Jamaica. DiabetMed. 1999;16(10):S75-83.
6. Assuncao MC, Santos Id, Gigante DP. Atenção primária em diabetes no Sul do Brasil: estrutura, processo e resultado. Rev Saude Publica. 2001;35(1):88-95.
7. Baechler R, Mujica V, Aqueveque X, Ramos L, Soto A. Prevalencia de diabetes mellitus en la VII Región de Chile. Rev Med Chil. 2002;130 (11): 1257-64.
8. Wilks RJ, Sargeant LA, Gulliford MC, Reid ME, Forrester TE. Management of diabetes mellitus in three settings in Jamaica. Rev Panam Salud Publica. 2001;9(2):65-72.
9. Aguilar-Salinas CA, Velazquez Monroy O, Gomez-Perez FJ, Gonzalez Chavez A, Esqueda AL, Molina Cuevas V, et al. Characteristics of patients with type 2 diabetes in Mexico: results from a large population-based nationwide survev. Diabetes Care. 2003;26(7): 2021-6.
10. Barceló A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003; 81(1):19-27.
11. Gagliardino JJ, de la Hera M, Siri F, Grupo de Investigación de la Red QUALlDIAB. Evaluación de la calidad de la asistencia al paciente diabético en América Latina. Rev Panam Salud Publica. 2001;10(5):309-17.
12. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(Suppl 1)533-50.
13. Burlando G, Sánchez RA, Ramos FH, Mogensen CE, Zanchetti A and On behalf of the Latin American Experts Group. Latin American consensus on diabetes mellitus and hypertension. J Hypertens. 2004; 22: 2229-41.
14. Barceló A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Rev Panam Salud Publica. 2001;10(5):300-8.
15. Nelson KM, Reiber G, Boyko EJ, NHANES III. Diet and exercise among adults with type 2 diabetes: findings from the third national health and nutrition examination survey (NHANES III). Diabetes Care. 2002;25(10): 1722-8.
16. Harris SB, Ekoe JM, Zdanowicz Y, WebsterBogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract. 2005;70(1):90-7.
17. Kerner W. The UK prospective diabetes study [letter]. Lancet. 1998;352(9144):1934.
18. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421-31.
19. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12.
20. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002; 25:1129-34.
21. Hunt KJ, Williams K, Rivera D, O'Leary DH, Haffner SM, Stern MP, Gonzales Villalpando C. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vase Biol. 2003;23:1845-50.
22. Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413-20.
23. Chacra AR, Davidson JA, Diaz J, EscalantePulido M, Litwak LE, Mestman JH, et al. An algorithm for the treatment of type 2 diabetes in Latin America. Diabetes Obes Metab. 2005; 7(2):148-60.
24. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 2000;320(7246): 1373-8.